These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23479321)

  • 1. Systemic immune activation and microbial translocation in dual HIV/tuberculosis-infected subjects.
    Toossi Z; Funderburg NT; Sirdeshmuk S; Whalen CC; Nanteza MW; Johnson DF; Mayanja-Kizza H; Hirsch CS
    J Infect Dis; 2013 Jun; 207(12):1841-9. PubMed ID: 23479321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
    Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Makutu DK; Nfanyana K; Rantleru T; Tierney A; Nkakana K; Schwartz AB; Gross R; Macgregor RR; Bellamy SL; Frank I; Weissman D; Bisson GP
    J Infect Dis; 2013 Dec; 208(11):1784-93. PubMed ID: 23908475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of microbial translocation products (LPS, sCD14, IgM Endocab) in HIV-1 infected Indian individuals.
    Negi N; Singh R; Sharma A; Das BK; Vajpayee M
    Microb Pathog; 2017 Oct; 111():331-337. PubMed ID: 28801271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μL.
    Nanteza MW; Mayanja-Kizza H; Charlebois E; Srikantiah P; Lin R; Mupere E; Mugyenyi P; Boom WH; Mugerwa RD; Havlir DV; Whalen CC
    J Infect Dis; 2011 Sep; 204(6):884-92. PubMed ID: 21849285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.
    Wallet MA; Rodriguez CA; Yin L; Saporta S; Chinratanapisit S; Hou W; Sleasman JW; Goodenow MM
    AIDS; 2010 Jun; 24(9):1281-90. PubMed ID: 20559035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
    J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol use predicts elevation in inflammatory marker soluble CD14 in men living with HIV.
    Monnig MA; Kahler CW; Cioe PA; Tucker L; Monti PM; Mayer KH; Ramratnam B
    AIDS Care; 2016 Nov; 28(11):1434-40. PubMed ID: 27242060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune activation is associated with increased gut microbial translocation in treatment-naive, HIV-infected children in a resource-limited setting.
    Pilakka-Kanthikeel S; Kris A; Selvaraj A; Swaminathan S; Pahwa S
    J Acquir Immune Defic Syndr; 2014 May; 66(1):16-24. PubMed ID: 24378729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection.
    Serpa JA; Rueda AM; Somasunderam A; Utay NS; Lewis D; Couturier JP; Breaux KG; Rodriguez-Barradas M
    Clin Infect Dis; 2017 Oct; 65(10):1638-1643. PubMed ID: 29020215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS).
    Viladés C; Escoté X; López-Dupla M; Martinez E; Domingo P; Asensi V; Leal M; Peraire J; Inza MI; Arnedo M; Gutiérrez M; Valle-Garay E; Ferrando-Martinez S; Olona M; Alba V; Sirvent JJ; Gatell JM; Vidal F;
    J Antimicrob Chemother; 2014 Jun; 69(6):1653-9. PubMed ID: 24535275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased gut microbial translocation in HIV-infected children persists in virologic responders and virologic failures after antiretroviral therapy.
    Pilakka-Kanthikeel S; Huang S; Fenton T; Borkowsky W; Cunningham CK; Pahwa S
    Pediatr Infect Dis J; 2012 Jun; 31(6):583-91. PubMed ID: 22333700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune reconstitution in HIV+ subjects on lopinavir/ritonavir-based HAART according to the severity of pre-therapy CD4+.
    Marchetti G; Merlini E; Sinigaglia E; Iannotti N; Bai F; Savoldi A; Tincati C; Carpani G; Bini T; Arminio Monforte A
    Curr HIV Res; 2012 Oct; 10(7):597-605. PubMed ID: 22716104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in frequencies of circulating Th-17 cells correlates with microbial translocation, immune activation and exhaustion in HIV-1 infected patients with poor CD4 T-cell reconstitution.
    Valiathan R; Asthana D
    Immunobiology; 2016 May; 221(5):670-8. PubMed ID: 26817581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.
    Hermans SM; Manabe YC; Kiragga AN; Hoepelman AI; Lange JM; van Leth F
    Antivir Ther; 2013; 18(4):615-22. PubMed ID: 23423604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.
    Mahan CS; Walusimbi M; Johnson DF; Lancioni C; Charlebois E; Baseke J; Chervenak KA; Mugerwa RD; Havlir DV; Mayanja-Kizza H; Whalen CC; Boom WH;
    PLoS One; 2010 Feb; 5(2):e9138. PubMed ID: 20179751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease.
    Meng Q; Sayin I; Canaday DH; Mayanja-Kizza H; Baseke J; Toossi Z
    PLoS One; 2016; 11(11):e0166954. PubMed ID: 27870882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans.
    Eller MA; Blom KG; Gonzalez VD; Eller LA; Naluyima P; Laeyendecker O; Quinn TC; Kiwanuka N; Serwadda D; Sewankambo NK; Tasseneetrithep B; Wawer MJ; Gray RH; Marovich MA; Michael NL; de Souza MS; Wabwire-Mangen F; Robb ML; Currier JR; Sandberg JK
    PLoS One; 2011 Apr; 6(4):e18779. PubMed ID: 21526194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections.
    Nowroozalizadeh S; Månsson F; da Silva Z; Repits J; Dabo B; Pereira C; Biague A; Albert J; Nielsen J; Aaby P; Fenyö EM; Norrgren H; Holmgren B; Jansson M
    J Infect Dis; 2010 Apr; 201(8):1150-4. PubMed ID: 20199244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3.
    Lancioni CL; Mahan CS; Johnson DF; Walusimbi M; Chervenak KA; Nalukwago S; Charlebois E; Havlir D; Mayanja-Kizza H; Whalen CC; Boom WH
    J Infect Dis; 2011 Apr; 203(7):992-1001. PubMed ID: 21402550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.